Related Experiment Videos
Audit of the de Haen Drugs-In-Use Drug Information System
Insights
An audit of de Haen abstracts revealed significant reliability issues. Many abstracts contained errors in accuracy, completeness, and judgment, urging users to consult original sources for drug information.
Area of Science:
- Pharmacovigilance
- Drug Information Science
Background:
- The de Haen Drugs-In-Use Drug Information System is a resource for accessing drug information.
- Evaluating the reliability of secondary drug information sources is crucial for healthcare professionals.
Purpose of the Study:
- To audit the de Haen Drugs-In-Use Drug Information System abstracts for accuracy, completeness, and judgment.
- To assess the overall reliability of the de Haen abstracts as a drug information source.
Main Methods:
- A systematic audit of 100 de Haen abstracts was performed.
- Each abstract was compared against the original publication for accuracy and completeness.
- Abstraction judgment was also evaluated.
Main Results:
- Forty-six out of 100 audited abstracts contained at least one error.
- A total of 66 errors were identified across the abstracts.
- Errors were categorized into accuracy (47), completeness (15), and judgment (4).
Conclusions:
- The de Haen abstracts demonstrate significant reliability issues.
- Users should utilize de Haen abstracts primarily for literature access, not as a sole source of drug information.
- Verification with original research articles is recommended for critical drug information.
Abstract:
An audit of 100 abstracts from the de Haen Drugs-In-Use Drug Information System was conducted to determine the reliability of this drug information source. The original article was reviewed and compared with the information contained on the corresponding de Haen card. The card was audited for accuracy, completeness and judgment of abstraction. Forty-six cards contained at least one error. A total of 66 errors were observed: 47 involved errors of accuracy, 15 involved errors of completeness and 4 involved errors in judgment. The subscriber is urged to use the de Haen abstracts as a means of literature access only, and not as a primary source of drug information.